Malignant mesothelioma is a challenging cancer to treat. New therapies like T cell receptor fusion constructs (TRuCs) show promise. Determining which patients will benefit from these treatments is important. Radiomics, a field that extracts data from medical images, offers a potential solution. Radiomics may predict treatment responses based on imaging[…]
From the blog
Collapsed Lung and Mesothelioma
A new article highlights the link between a collapsed lung and mesothelioma. Mesothelioma, caused by asbestos exposure, can present unexpectantly. It often requires many clinical tests for accurate diagnosis and treatment planning. A new study explores the case of a 73-year-old man whose recurrent collapsing lung was found to be[…]
PITAC to Treat Mesothelioma
A Stanford team performed a specialized procedure for pleural mesothelioma for the very first time in North America. It is known as pressurized intrathoracic aerosol chemotherapy (PITAC), and it delivers chemotherapy directly to the chest as a pressurized mist. One doctor knows it as “spray paint chemo.” PITAC is minimally[…]
Blood Test Did Not Reduce Late Stage Cancer Diagnoses
A major clinical trial found that a blood test designed to detect cancer early did not reduce the number of late-stage diagnoses. Grail, the manufacturer of the test, reported the findings. The results suggest multi-cancer blood tests may not be as effective as anticipated. The Galleri test looks for fragments[…]
Pleurectomy/Decortication Surgery Has Low Mortality When Patients are Carefully Selected
A new study out of the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center finds lung-sparing pleurectomy/decortication (P/D) surgery has a very low rate of early mortality. These findings are in direct contrast to those from the MARS2 trial, which reported P/D surgery carried[…]
Tumor Treating Fields to Treat Mesothelioma and Other Hard to Treat Cancers
Tumor treating fields are an innovative new way to treat cancer. They do not involve surgery or drugs. They are also known as TTFields. TTFields have been approved by the FDA for the use of treating mesothelioma. Mesothelioma is a rare and aggressive cancer that affects the lining of certain[…]
Artificial Intelligence and Mesothelioma
Diagnosing lung diseases can be hard because they have many causes and symptoms. Artificial intelligence may enable faster and more accurate diagnosis. AI could potentially play a role in improving outcomes for mesothelioma patients as well as other lung diseases. One common lung problem is pleural effusion. This can make[…]
Photodynamic Therapy to Treat Mesothelioma
Cancer treatment has made significant improvements in recent years, thanks to advancements in technology. One technology being used is 3D printing and scanning. Together they are enhancing the accuracy and effectiveness of cancer treatments. This includes photodynamic therapy for malignant pleural mesothelioma and other cancers. Photodynamic therapy (PDT) is a[…]
Tretinoin and Chemotherapy
Tretinoin is a derivative of vitamin A. It has the potential to enhance the effects of chemotherapy. Combining tretinoin with chemotherapy improved survival rates in mesothelioma in mice. Mesothelioma is a rare cancer that is hard to diagnose and treat. It develops on the thin layer of tissue that surrounds[…]
Fibroblasts’ Role in Mesothelioma Development
Malignant mesothelioma is a cancer that is mainly caused by asbestos exposure. Asbestos was once used in construction and other trades. Mesothelioma is a cancer that grows and spreads rapidly, making it dangerous. Treatment options are limited for the cancer. Asbestos is no longer used in many places, but people[…]
Skip to content